8302 1234 annette.paschke@unisa.edu.au
Hello, I'm Libby Roughead, a Bradley Distinguished Professor at the University of South Australia and Director of the Quality Use of Medicines and Pharmacy Research Centre.
Our research focuses on quantifying the extent of problems with medicines use, identifying the extent of harm from medicines, testing solutions for improving medicines use and evaluating improvements in health care.
We work with consumers, health professionals and organisations, ensuring the advanced technologies and methods developed within the centre find their way into policy and practice to improve patient lives.
Our research ranges from large-scale data analysis to the translation of evidence into policy and practice.
We identify... Read more
About me
Hello, I'm Libby Roughead, a Bradley Distinguished Professor at the University of South Australia and Director of the Quality Use of Medicines and Pharmacy Research Centre.
Our research focuses on quantifying the extent of problems with medicines use, identifying the extent of harm from medicines, testing solutions for improving medicines use and evaluating improvements in health care.
We work with consumers, health professionals and organisations, ensuring the advanced technologies and methods developed within the centre find their way into policy and practice to improve patient lives.
Our research ranges from large-scale data analysis to the translation of evidence into policy and practice.
We identify harms from medicines and the effectiveness of different pharmaceutical policies. This research supports policy makers to improve pharmaceutical policy.
We focus on consumer and health professional involvement in all stages of research and test interventions to improve health service delivery to reduce harm and improve outcomes from medicine use . This research has had a direct impact on the Australian health care system, improving patient outcomes.
We run, on behalf of the Australian Government Department of Veterans' Affairs, the Veterans' Medicines Advice and Therapeutics Education Services (MATES) program. This ongoing program has delivered over 65 therapeutic interventions and targeted every general practioner, pharmacy, aged-care facility and veteran in Australia. The program has led to improvements in medicine use and reductions in hospitalisations.
Our research focuses on 6 key areas: medicines safety, optimising medicine use, digital health, pharmacy practice, Aboriginal traditional medicines, and evidence translation and policy.
Our PhD students are undertaking research in all areas of medicine use, including developing methods to better detect medicine related harm, pharmacoepidemiology and pharmacovigilance, drug utilisation, testing new models of pharmacy and health care practice; integrating digital health initiatives into health service delivery. We welcome inquiries for you to join us.
About me
About me
| Date | Title |
|---|---|
| 20/11/2018 |
Improving Medication Safety, https://www.unisa.edu.au/EnterprisingResearchTalks/Talks/Libby-Roughead/ |
| 24/10/2014 |
Knowledge Works Seminar: Medication Safety; new challenges in the 21st century, https://www.youtube.com/watch?v=gexXGsUXOq0 |
| 26/09/2014 |
Successful Ageing Seminar: Are your pills making you ill?, https://lrs.unisa.edu.au/ess/echo/presentation/fcaee3c9-89ae-4c5d-ae4b-5134f55b9d4a/media.m4v |
About me
Doctor of Philosophy University of South Australia
Master of Applied Science La Trobe University
Graduate Diploma of Health Education and Promotion La Trobe University
Bachelor of Pharmacy Victorian College of Pharmacy Limited
Research
Excludes commercial-in-confidence projects.
Deed: RFQ Therapeutic Goods Evaluation and Advice Panel, Cwth Dept of Health Aged Care, 30/07/2024 - 30/06/2027
Veterans' Medicines Advice and Therapeutics Education Services (Veterans' MATES) Program, Cwth Dept of Veterans' Affairs, 01/09/2015 - 30/06/2027
Enhancing mental health care through a real-time Quality Use of Medicines (QUM) data analytics dashboard in acute mental health hospitals, Cwth Dept of Foreign Affairs and Trade, 22/07/2024 - 21/07/2026
Analysis of PBS data for National Report on Antimicrobial Use and Resistance 2024, Australian Commission on Safety and Quality in Health Care, 17/04/2025 - 31/08/2025
QUM in Schools and Childcare settings, Australian Commission on Safety and Quality in Health Care, 02/12/2024 - 30/04/2025
Medication Safety in Children: Literature review, Pharmaceutical Society of Australia, 23/07/2024 - 28/02/2025
Turning antimicrobial resistance in residential aged care inside-out from the patient to facility level, MRFF - Targeted Call for Research - Antimicrobial Resistance, 26/06/2018 - 30/06/2024
Quality Use of Medicines Literature Review PH23/5815, Cwth Dept of Health Aged Care, 22/06/2023 - 17/05/2024
Large scale evidence generation for the utilisation and safety of biologic medicines, NHMRC - Project Grant, 01/01/2019 - 31/12/2023
Strengthening responses to dementia: Building an evidence platform for the development of a Vietnam National Dementia Plan, NHMRC-NAFOSTED Joint Call for Collaborative Research Projects, 01/04/2019 - 31/03/2022
Using Big Data to improve medication use and safety, NHMRC - Research Fellowship, 01/01/2016 - 31/12/2021
Veterans' Medicines Advice and Therapeutics Education Services (Veterans' MATES) Program, Cwth Dept of Veterans' Affairs, 01/09/2015 - 31/12/2021
Establishment of a health data analytics panel, Cwth Dept of Health Aged Care, 01/09/2016 - 08/12/2021
Utilisation review of prostacyclin analogue medicines for the treatment of pulmonary arterial hypertension (PAH), Cwth Dept of Health Aged Care, 26/03/2021 - 15/10/2021
PBS/RPBS Data Analysis and Report for the Antimicrobial use and resistance in Australia (AURA) Program, Australian Commission on Safety and Quality in Health Care, 21/01/2021 - 30/06/2021
ReMinDAR Trial: Reducing medicine induced deterioration and adverse reactions trial, Cwth Dept of Health Aged Care, 15/09/2017 - 31/03/2021
How best to protect public health: a comparative analysis of regulatory safety warnings on medicines in Australia, Canada the European Union and the United States, NHMRC - Project Grant, 01/01/2017 - 31/12/2020
CVC Mental Health Pilot, Cwth Dept of Veterans' Affairs, 03/01/2018 - 31/12/2020
Why is there an increased risk of severe adverse perinatal outcomes after the use of clomiphene citrate for infertility treatment?, NHMRC - Project Grant, 01/01/2018 - 31/12/2020
Centre of Research Excellence in post-market surveillance of medicines and medical devices, NHMRC - Centre of Research Excellence, 01/11/2012 - 31/10/2018
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2017 |
Open access
19
19
7
|
| 2016 |
Open access
102
88
259
|
| 2015 |
Open access
36
33
2
|
| 2015 |
Open access
1179
1030
508
|
| 2014 |
Open access
102
87
|
| Year | Output |
|---|---|
| 2024 |
|
| 2023 |
Open access
|
| 2018 |
1
|
| 2017 |
9
|
| 2015 |
9
|
| 2015 |
10
|
| 2015 |
8
3
|
| Year | Output |
|---|---|
| 2025 |
Open access
|
| 2025 |
Open access
3
|
| 2025 |
Open access
5
|
| 2025 |
Open access
|
| 2025 |
Open access
1
1
1
|
| 2024 |
Open access
|
| 2024 |
Open access
2
|
| 2024 |
Open access
2
4
|
| 2024 |
Open access
3
3
53
|
| 2024 |
Open access
2
2
|
| 2024 |
Open access
3
|
| 2024 |
Open access
7
7
|
| 2023 |
Open access
3
|
| 2023 |
Open access
1
4
|
| 2023 |
Open access
2
3
4
|
| 2023 |
Open access
6
7
2
|
| 2023 |
Open access
2
2
2
|
| 2023 |
4
3
6
|
| 2023 |
Open access
3
4
11
|
| 2023 |
Open access
6
6
7
|
| 2023 |
Open access
3
3
5
|
| 2023 |
9
5
6
|
| 2023 |
Open access
1
1
5
|
| 2022 |
Open access
5
5
6
|
| 2022 |
Open access
1
|
| 2022 |
Open access
|
| 2022 |
Open access
3
4
|
| 2022 |
3
3
7
|
| 2022 |
Open access
2
1
3
|
| 2022 |
Open access
3
3
9
|
| 2022 |
Open access
3
3
|
| 2022 |
Open access
61
58
204
|
| 2022 |
Open access
2
2
|
| 2022 |
10
10
2
|
| 2022 |
Open access
4
3
1
|
| 2022 |
Open access
8
6
27
|
| 2022 |
Open access
1
1
6
|
| 2022 |
Open access
11
10
|
| 2022 |
Open access
20
19
88
|
| 2022 |
Open access
1
1
1
|
| 2022 |
Open access
|
| 2022 |
Open access
16
13
9
|
| 2022 |
11
8
1
|
| 2021 |
12
10
54
|
| 2021 |
Open access
36
30
4
|
| 2021 |
Open access
6
5
8
|
| 2021 |
Open access
1
1
4
|
| 2021 |
Open access
8
8
|
| 2021 |
Open access
2
1
2
|
| 2021 |
Open access
4
4
7
|
| 2021 |
Open access
14
14
5
|
| 2021 |
Open access
3
3
26
|
| 2021 |
3
3
6
|
| 2021 |
2
1
5
|
| 2020 |
Open access
3
3
2
|
| 2020 |
Open access
5
4
|
| 2020 |
Open access
3
3
10
|
| 2020 |
Open access
5
6
3
|
| 2020 |
Open access
4
5
5
|
| 2020 |
Open access
11
11
3
|
| 2020 |
Open access
4
4
|
| 2020 |
1
|
| 2020 |
Open access
|
| 2020 |
Open access
21
26
|
| 2020 |
Open access
2
2
5
|
| 2020 |
Open access
7
7
2
|
| 2020 |
Open access
1
1
6
|
| 2020 |
Open access
23
24
27
|
| 2020 |
Open access
11
10
1
|
| 2020 |
Open access
11
9
2
|
| 2019 |
Open access
8
8
5
|
| 2019 |
Open access
9
9
1
|
| 2019 |
9
9
2
|
| 2019 |
2
2
13
|
| 2019 |
Open access
4
4
3
|
| 2019 |
Open access
6
2
|
| 2019 |
Open access
6
|
| 2019 |
5
5
|
| 2019 |
11
10
23
|
| 2019 |
1
4
|
| 2019 |
Open access
6
6
8
|
| 2019 |
Open access
42
40
9
|
| 2019 |
Open access
3
3
2
|
| 2019 |
Open access
30
29
3
|
| 2019 |
2
|
| 2019 |
Open access
9
9
|
| 2019 |
Open access
7
6
1
|
| 2019 |
13
12
4
|
| 2019 |
Open access
27
26
30
|
| 2019 |
6
5
2
|
| 2019 |
Open access
7
6
100
|
| 2018 |
7
7
2
|
| 2018 |
Open access
3
3
|
| 2018 |
Open access
10
8
7
|
| 2018 |
Open access
6
6
|
| 2018 |
Open access
15
14
1
|
| 2018 |
Open access
5
4
1
|
| 2018 |
Open access
25
20
2
|
| 2018 |
Open access
24
22
1
|
| 2018 |
Open access
1
|
| 2018 |
Open access
4
4
9
|
| 2018 |
Open access
7
8
|
| 2018 |
Open access
7
13
|
| 2018 |
10
10
6
|
| 2018 |
Open access
11
10
|
| 2018 |
Open access
3
3
3
|
| 2018 |
60
53
10
|
| 2018 |
Open access
15
10
12
|
| 2018 |
Open access
15
12
12
|
| 2018 |
Open access
22
26
|
| 2018 |
Open access
12
|
| 2018 |
Open access
210
208
21
|
| 2018 |
Open access
232
220
205
|
| 2018 |
21
17
3
|
| 2018 |
6
|
| 2018 |
Open access
15
12
|
| 2018 |
30
31
3
|
| 2018 |
Open access
2
2
1
|
| 2018 |
Open access
17
|
| 2018 |
Open access
9
8
2
|
| 2017 |
Open access
18
17
8
|
| 2017 |
17
15
10
|
| 2017 |
Open access
24
22
14
|
| 2017 |
Open access
48
46
1
|
| 2017 |
Open access
26
23
14
|
| 2017 |
98
95
10
|
| 2017 |
Open access
165
146
11
|
| 2017 |
Open access
6
6
|
| 2017 |
6
6
12
|
| 2017 |
3
2
|
| 2017 |
Open access
95
81
17
|
| 2017 |
Open access
5
4
|
| 2017 |
|
| 2017 |
17
3
|
| 2017 |
4
3
|
| 2017 |
Open access
14
6
|
| 2017 |
Open access
11
6
|
| 2017 |
Open access
1
1
11
|
| 2017 |
Open access
15
12
9
|
| 2017 |
1
1
|
| 2017 |
Open access
27
21
18
|
| 2017 |
Open access
19
19
7
|
| 2017 |
Open access
2
2
1
|
| 2016 |
Open access
13
15
27
|
| 2016 |
Open access
11
8
|
| 2016 |
Open access
7
7
|
| 2016 |
Open access
14
12
3
|
| 2016 |
Open access
30
24
|
| 2016 |
Open access
|
| 2016 |
Open access
176
162
15
|
| 2016 |
Open access
46
42
16
|
| 2016 |
31
24
49
|
| 2016 |
8
8
7
|
| 2016 |
Open access
5
3
1
|
| 2016 |
10
9
2
|
| 2016 |
Open access
42
35
|
| 2016 |
Open access
30
26
1
|
| 2016 |
Open access
34
31
4
|
| 2016 |
Open access
118
106
13
|
| 2016 |
12
13
|
| 2016 |
Open access
102
88
259
|
| 2016 |
19
19
|
| 2016 |
Open access
17
17
6
|
| 2016 |
Open access
2
9
|
| 2015 |
Open access
6
6
10
|
| 2015 |
2
1
|
| 2015 |
Open access
6
5
|
| 2015 |
Open access
15
|
| 2015 |
Open access
14
12
1
|
| 2015 |
Open access
18
13
|
| 2015 |
Open access
26
24
2
|
| 2015 |
11
10
1
|
| 2015 |
|
| 2015 |
Open access
52
48
|
| 2015 |
2
2
2
|
| 2015 |
Open access
4
2
7
|
| 2015 |
Open access
|
| 2015 |
Open access
10
47
5
|
| 2015 |
6
6
4
|
| 2015 |
Open access
17
13
9
|
| 2015 |
Open access
2
2
|
| 2015 |
Open access
4
3
|
| 2015 |
Open access
36
33
2
|
| 2015 |
Open access
1179
1030
508
|
| 2015 |
Open access
7
18
|
| 2015 |
16
13
|
| 2015 |
Open access
35
36
6
|
| 2014 |
Open access
|
| 2014 |
Open access
|
| 2014 |
Open access
20
19
|
| 2014 |
Open access
102
87
|
| 2014 |
Open access
8
7
|
| 2014 |
Open access
41
41
|
| 2014 |
Open access
80
65
|
| 2014 |
Open access
35
30
|
| 2014 |
Open access
35
33
|
| 2014 |
Open access
17
13
|
| 2014 |
21
39
|
| 2014 |
Open access
17
14
|
| 2014 |
32
31
|
| 2013 |
65
54
|
| 2013 |
Open access
53
49
|
| 2013 |
Open access
16
15
|
| 2013 |
Open access
11
11
|
| 2013 |
16
16
|
| 2013 |
Open access
7
7
|
| 2013 |
8
|
| 2013 |
Open access
20
22
|
| 2013 |
Open access
25
24
|
| 2013 |
6
|
| 2013 |
49
44
|
| 2013 |
Open access
24
22
|
| 2013 |
Open access
29
28
|
| 2013 |
Open access
|
| 2013 |
Open access
8
|
| 2013 |
Open access
|
| 2013 |
13
11
|
| 2013 |
64
58
|
| 2012 |
Open access
|
| 2012 |
8
7
|
| 2012 |
Open access
62
52
|
| 2012 |
Open access
10
11
|
| 2012 |
35
33
|
| 2012 |
Open access
40
|
| 2012 |
Open access
41
37
|
| 2012 |
31
25
|
| 2012 |
9
10
|
| 2011 |
Open access
13
|
| 2011 |
Open access
52
39
|
| 2011 |
36
25
|
| 2011 |
4
|
| 2011 |
14
11
|
| 2011 |
4
4
|
| 2011 |
5
4
|
| 2011 |
17
18
|
| 2011 |
Open access
77
57
|
| 2011 |
Open access
19
20
|
| 2011 |
|
| 2011 |
Open access
35
30
|
| 2011 |
84
80
|
| 2011 |
72
65
|
| 2011 |
Open access
7
7
|
| 2011 |
35
36
|
| 2011 |
44
|
| 2011 |
52
45
|
| 2011 |
5
4
|
| 2010 |
57
52
|
| 2010 |
Open access
47
41
|
| 2010 |
Open access
56
42
|
| 2010 |
10
7
|
| 2010 |
70
66
|
| 2010 |
Killer, G, Peck, R, Ryan, P, Ramsay, E, Roughead, EE, Barratt, JD, Pratt, N & Gilbert, AL 2010, 'Collaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veterans', Journal of Clinical Pharmacy and Therapeutics. |
| 2010 |
Open access
16
14
|
| 2010 |
Open access
28
18
|
| 2010 |
30
28
|
| 2010 |
29
32
|
| 2010 |
Open access
12
8
|
| 2010 |
11
11
|
| 2010 |
5
5
|
| 2010 |
23
17
|
| 2010 |
156
140
|
| 2010 |
Open access
34
32
|
| 2010 |
Open access
75
65
|
| 2010 |
9
|
| 2010 |
13
13
|
| 2010 |
Open access
22
22
|
| 2010 |
14
10
|
| 2009 |
Open access
24
24
|
| 2009 |
|
| 2009 |
Open access
|
| 2009 |
Open access
90
70
|
| 2009 |
Open access
155
|
| 2009 |
Open access
119
89
|
| 2009 |
17
15
|
| 2009 |
28
23
|
| 2009 |
Open access
41
|
| 2009 |
Open access
94
89
|
| 2008 |
Open access
180
155
|
| 2008 |
86
85
|
| 2008 |
|
| 2008 |
13
9
|
| 2008 |
17
|
| 2008 |
Open access
|
| 2008 |
7
7
|
| 2008 |
Open access
19
16
|
| 2008 |
24
21
|
| 2008 |
32
31
|
| Year | Output |
|---|---|
| 2022 |
Open access
|
| 2020 |
Open access
|
| 2019 |
Open access
|
| 2018 |
Open access
|
| 2017 |
Open access
|
| 2016 |
Open access
|
Methods to analyse medicine utilization and expenditure to support pharmaceutical policy implementation: WHO
Medication safety in acute care in Australia: where are we now? Part 1, Part 2
Second National Report on Patient Safety – Improving Medication Safety
Research
External engagement & recognition
| Organisation | Country |
|---|---|
| Advanced Digital Sciences Center | SINGAPORE |
| Astellas Pharma | JAPAN |
| Asthma Australia | AUSTRALIA |
| Asthma Australia Ltd | AUSTRALIA |
| Asthma SA | AUSTRALIA |
| Austin Health | AUSTRALIA |
| Australian Health Practitioner Regulation Agency | AUSTRALIA |
| Australian National University | AUSTRALIA |
| Australian Nursing and Midwifery Federation (SA Branch) | AUSTRALIA |
| Australian Orthopaedic Association | AUSTRALIA |
| Bond University | AUSTRALIA |
| Bupa Health Foundation (formerly MBF Foundation) | AUSTRALIA |
| Charles Darwin University | AUSTRALIA |
| Chonnam National University | KOREA, REPUBLIC OF (SOUTH) |
| Curtin University | AUSTRALIA |
| Cyberjaya University College of Medical Sciences | MALAYSIA |
| Dalhousie University | CANADA |
| Deakin University | AUSTRALIA |
| Department of Health | TAIWAN |
| Department of Health - NSW | AUSTRALIA |
| Department of Health and Ageing | AUSTRALIA |
| Department of Health, Manila | PHILIPPINES |
| Department of Veterans Affairs | AUSTRALIA |
| Duke Clinical Research Institute | UNITED STATES |
| Duke University | UNITED STATES |
| Flinders University | AUSTRALIA |
| George Washington University | UNITED STATES |
| Griffith University | AUSTRALIA |
| Hamamatsu University | JAPAN |
| Hanoi Medical University | VIET NAM |
| Harvard University | UNITED STATES |
| Health Canada | CANADA |
| Health Insurance Review and Assessment Service | KOREA, REPUBLIC OF (SOUTH) |
| Health Sciences Authority | SINGAPORE |
| Healthy Care Services Pty Ltd | AUSTRALIA |
| Helping Hand Aged Care | AUSTRALIA |
| Helping Hand Organisation | AUSTRALIA |
| Hornsby Ku-ring-gai Hospital | AUSTRALIA |
| Institute of Population, Health and Development | VIET NAM |
| Iranian Ministry of Health and Medical Education | IRAN |
| Jewish General Hospital | CANADA |
| Kaiser Permanente | UNITED STATES |
| Karolinska Institute | SWEDEN |
| Korea Institute of Drug Safety and Risk Management | KOREA, REPUBLIC OF (SOUTH) |
| Macquarie University | AUSTRALIA |
| Mahidol University | THAILAND |
| Mater Adult Hospital | AUSTRALIA |
| McGill University | CANADA |
| McMaster University | CANADA |
| Medicines Information Service | AUSTRALIA |
| Ministry Health | UNITED STATES |
| Ministry of Health | IRAQ |
| Ministry of Health, Malaysia | MALAYSIA |
| Ministry of Public Health | THAILAND |
| Monash University | AUSTRALIA |
| Monash University Malaysia | MALAYSIA |
| Naresuan University | THAILAND |
| National Ageing Research Institute | AUSTRALIA |
| National Cheng Kung University | TAIWAN |
| National Cheng Kung University Hospital | TAIWAN |
| National Geriatric Hospital of Vietnam | VIET NAM |
| National Health Insurance Service | KOREA, REPUBLIC OF (SOUTH) |
| National Prescribing Service | AUSTRALIA |
| National University of Malaysia | MALAYSIA |
| Nihon University | JAPAN |
| niversity of Notre Dame | UNITED STATES |
| Northern Territory Department of Health | AUSTRALIA |
| NPO Drug Safety | JAPAN |
| NPO Drug Safety Research Unit | JAPAN |
| NPS Better Choices Better Health | AUSTRALIA |
| NPS MedicineWise | AUSTRALIA |
| Oxford University | UNITED KINGDOM |
| Parliament House, Canberra | AUSTRALIA |
| Pharmaceutical Society of Australia | AUSTRALIA |
| Pharmacy Improvement Centre Ltd | AUSTRALIA |
| Private Individual | UNITED KINGDOM |
| Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences | AUSTRALIA |
| Queen's University | CANADA |
| Queensland Health | AUSTRALIA |
| Royal Adelaide Hospital | AUSTRALIA |
| Royal Children's Hospital, Victoria | AUSTRALIA |
| Royal Perth Hospital | AUSTRALIA |
| Rutgers University | UNITED STATES |
| SA Health | AUSTRALIA |
| SA Pathology | AUSTRALIA |
| Seoul National University | KOREA, REPUBLIC OF (SOUTH) |
| Sichuan University | CHINA |
| South Australian Department of Health | AUSTRALIA |
| South Australian Health and Medical and Research Institute (SAHMRI) | AUSTRALIA |
| Southern Cross Care (SA) | AUSTRALIA |
| Sung Kyun Kwan University | KOREA, REPUBLIC OF (SOUTH) |
| Sungkyunkwan University (SKKU) | KOREA, REPUBLIC OF (SOUTH) |
| Swedish Hip Arthroplasty Register | SWEDEN |
| Swinburne University of Technology | AUSTRALIA |
| Syddansk Universitet | DENMARK |
| Taibah University | SAUDI ARABIA |
| Tanunda Lutheran Home Inc | AUSTRALIA |
| Tehran University of Medical Sciences | IRAN |
| Telethon Institute for Child Health Research | AUSTRALIA |
| The University of Notre Dame Australia | AUSTRALIA |
| The University of Wollongong | AUSTRALIA |
| Tohoku University Graduate School of Medicine | JAPAN |
| Tokyo University of Science | JAPAN |
| Ubon Ratchathani University | THAILAND |
| Universiti Kabangsaan Malaysia | MALAYSIA |
| University College London | UNITED KINGDOM |
| University of Aberdeen | UNITED KINGDOM |
| University of Adelaide | AUSTRALIA |
| University of British Columbia | CANADA |
| University of California | UNITED STATES |
| University of California, Los Angeles | UNITED STATES |
| University of Colorado Anschutz Medical Campus | UNITED STATES |
| University of Colorado Denver | UNITED STATES |
| University of Copenhagen | DENMARK |
| University of Hong Kong | HONG KONG |
| University of Illinois at Urbana-Champaign | UNITED STATES |
| University of Melbourne | AUSTRALIA |
| University of Montreal | CANADA |
| University of New South Wales | AUSTRALIA |
| University of Newcastle | AUSTRALIA |
| University of Oxford | UNITED KINGDOM |
| University of Queensland | AUSTRALIA |
| University of Science, Malaysia | MALAYSIA |
| University of South Australia | AUSTRALIA |
| University of South Carolina - Columbia | UNITED STATES |
| University of Sydney | AUSTRALIA |
| University of Tasmania | AUSTRALIA |
| University of Technology Sydney | AUSTRALIA |
| University of Tokyo | JAPAN |
| University of Toronto | CANADA |
| University of Utah | UNITED STATES |
| University of Washington | UNITED STATES |
| University of Western Australia | AUSTRALIA |
| University School of Medicine | UNITED STATES |
| Utrecht University | NETHERLANDS |
| Veterans’ Medicines Advice and Therapeutics EducationServices (Veterans’ MATES) | AUSTRALIA |
| Washington State University | UNITED STATES |
| Women's and Children's Hospital | AUSTRALIA |
| World Health Organisation | SWITZERLAND |
| Yonsei University | KOREA, REPUBLIC OF (SOUTH) |
| York University | CANADA |
External engagement & recognition
| Engagement/recognition | Year |
|---|---|
Invited Speaker - Medication safety in aged-care: our role and responsibilityConPharm Australian Association of Consultant Pharmacists |
2020 |
Invited Speaker - Medication Safety: Do no harmCentral Adelaide Health Network |
2020 |
Invited speaker - People Improving the Use of Medicines: What We Know and Don't KnowInternational Society for Improving Use of Medicines |
2020 |
Invited speaker at conferenceInternational Society for Pharmacovigilance |
2020 |
Member of an advisory board - Research and Evaluation Reference GroupAustralian Digital Health Agency |
2020 |
Plenary speaker - Initiatives to improve the use of medicines: Australia's experiencePeople, purpose, passion: the pathway to success for rational drug use country. Side meeting of the Prince Mahidol Awards Conference |
2020 |
Advisory Board MemberAustralian Centre of Excellence for Post Traumatic Stress |
2019 |
Associate EditorInternational Society of Pharmacoepidemiology and Drug Safety |
2019 |
Drug Utilisation Sub Committee of the Pharmaceutical Benefits Advisory Committee MemberDepartment of Health |
2019 |
Editorial Board MemberDrug Safety Case Reports |
2019 |
FellowInternational Society of Pharmacoepidemiology |
2019 |
MemberHealth Services Research Association of Australia and New Zealand (HSRAANZ) |
2019 |
MemberInternational Society for Pharmacovigilance |
2019 |
MemberAustralasian Pharmaceutical Science Association (APSA) |
2019 |
Research Australia University Roundtable Invited SpeakerResearch Australia |
2019 |
Safety and Quality Committee MemberAustralian Digital Health Agency |
2019 |
Senior Principle Research FellowshipNational Health and Medical Research Council |
2019 |
Winner - The Health Services AwardResearch Australia |
2019 |
Advisory Board MemberAustralian Centre of Excellence for Post Traumatic Stress |
2018 |
Associate EditorInternational Society of Pharmacoepidemiology and Drug Safety |
2018 |
Editorial Board MemberDrug Safety Case Reports |
2018 |
FellowInternational Society of Pharmacoepidemiology |
2018 |
MemberInternational Society for Pharmacovigilance |
2018 |
Member: Advisory CommitteeAustralian Centre of Excellence for Post Traumatic Stress |
2018 |
Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory CommitteeDepartment of Health, Australian Government |
2018 |
Safety and Quality Committee MemberAustralian Digital Health Agency |
2018 |
Senior Principle Research FellowshipNational Health and Medical Research Council |
2018 |
Working Group on using antimicrobial consumption data at country level - temporary advisorWorld Health Organisation |
2018 |
Associate EditorInternational Society of Pharmacoepidemiology and Drug Safety |
2017 |
DirectorQuality Use of Medicines and Pharmacy Research Centre |
2017 |
Distinguished investigator Award: Lifetime AchievementHealth Services Research Australia and New Zealand |
2017 |
Distinguished Investigator Life Time Achievement AwardHealth Services Research Association of Australia and New Zealand (HSRAANZ) |
2017 |
Editorial Board MemberDrug Safety Case Reports |
2017 |
FellowInternational Society of Pharmacoepidemiology (ISPE) |
2017 |
FellowInternational Society of Pharmacoepidemiology |
2017 |
MemberInternational Society for Pharmacovigilance |
2017 |
MemberInternational Society of Pharmacovigilance (ISOP) |
2017 |
Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory CommitteeDepartment of Health, Australian Government |
2017 |
Program LeaderVeterans Medicines Advice and Therapeutics Education Services - (V)MATES, Australian Government |
2017 |
Safety and Quality Committee MemberAustralian Digital Health Agency |
2017 |
Senior Principal Research FellowHealth Services Research Association Australia and New Zealand (HSRAANZ) |
2017 |
Senior Principle Research FellowshipNational Health and Medical Research Council |
2017 |
Associate EditorInternational Society of Pharmacoepidemiology and Drug Safety |
2016 |
Editorial Board MemberDrug Safety Case Reports |
2016 |
FellowInternational Society of Pharmacoepidemiology |
2016 |
MemberInternational Society for Pharmacovigilance |
2016 |
Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory CommitteeDepartment of Health, Australian Government |
2016 |
Senior Principle Research FellowshipNational Health and Medical Research Council |
2016 |
Associate EditorInternational Society of Pharmacoepidemiology and Drug Safety |
2015 |
Editorial Board MemberDrug Safety Case Reports |
2015 |
MemberInternational Society for Pharmacovigilance |
2015 |
Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory CommitteeDepartment of Health, Australian Government |
2015 |
Associate EditorInternational Society of Pharmacoepidemiology and Drug Safety |
2014 |
Editorial Board MemberDrug Safety Case Reports |
2014 |
MemberInternational Society for Pharmacovigilance |
2014 |
Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory CommitteeDepartment of Health, Australian Government |
2014 |
Associate EditorInternational Society of Pharmacoepidemiology and Drug Safety |
2013 |
MemberInternational Society for Pharmacovigilance |
2013 |
Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory CommitteeDepartment of Health, Australian Government |
2013 |
Associate EditorInternational Society of Pharmacoepidemiology and Drug Safety |
2012 |
MemberInternational Society for Pharmacovigilance |
2012 |
Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory CommitteeDepartment of Health, Australian Government |
2012 |
MemberInternational Society for Pharmacovigilance |
2011 |
Member: Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory CommitteeDepartment of Health, Australian Government |
2011 |
Future FellowshipAustralian Research Council (ARC) |
2010 |
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| 110402 - Precision dose calculation for medicine decision support systems | Current |
| Adverse drug reaction reporting by consumers in Australia | Current |
| Avoiding the harm: safe medication care pathways in hospitals | Current |
| Enriching pharmacoepidemiology with molecular similarity approaches in order to support adverse event detection | Current |
| Post-market Surveillenace of Coronary Stents: Use of Existing Data Sources | Current |
| The extended role of pharmacy professionals and the effectiveness of pharmacist-led service in the management of delirium among elderly patients in a resource-limited setting: the case of Ethiopia | Current |
| Developing computational methods for detecting signals of adverse drug events from healthcare data | Completed |
| Developing data mining methods for detecting signals of adverse drug events | Completed |
| Emerging role of pharmacists in preadmission clinics in prevention of postoperative delirium | Completed |
| Enhancing Australia's pharmaco-surveillance capacity: a validation of sequence symmetry analysis method | Completed |
| Fixed dose combination medicine use in cardiovascular disease: implications for quality use of medicines and subsidy in Australia | Completed |
| How do Governments manage uncertainty about pharmaceutical evidence while maintaining a transparent and rigorous decision-making process for public reimbursement of pharmaceuticals? | Completed |
| Medicines and the risk of hip fracture among older people: an investigation of medicine safety in administrative claims data | Completed |
| Quality of information in pharmaceutical promotion | Completed |
| Targeting medicines in the prevention of delirium in older patients: a principal role for pharmacists | Completed |
| Understanding frailty and its association with medicine use | Completed |
